We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01489566
Recruitment Status : Unknown
Verified December 2011 by Shenzhen Kangzhe Pharmaceutical Co., Ltd..
Recruitment status was:  Enrolling by invitation
First Posted : December 9, 2011
Last Update Posted : December 14, 2011
Fudan University
Medpace, Inc.
Information provided by (Responsible Party):
Shenzhen Kangzhe Pharmaceutical Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : March 2013
  Estimated Study Completion Date : August 2013